findmyKOL
Clinical trialNCT01612767CompletedPhase 2/PHASE3Interventional

BIOHELIX-I Bare Metal Stent Study

SponsorBiotronik, Inc.Enrollment329Coronary Arteries Disease
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

35 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Colombia
  • Facility name not stated

    Medellín, Colombia

Germany
  • Facility name not stated

    Bad Segeberg, Germany

  • Facility name not stated

    Essen, Germany

  • Facility name not stated

    Ludwigshafen, Germany

Latvia
  • Facility name not stated

    Riga, Latvia

Netherlands
  • Facility name not stated

    Amsterdam, Netherlands

  • Facility name not stated

    Eindhoven, Netherlands

United States
  • Facility name not stated

    Phoenix, Arizona, United States

  • Facility name not stated

    Concord, California, United States

  • Facility name not stated

    Mission Viejo, California, United States

  • Facility name not stated

    Danbury, Connecticut, United States

  • Facility name not stated

    New Haven, Connecticut, United States

  • Facility name not stated

    Washington D.C., District of Columbia, United States

  • Facility name not stated

    Gainesville, Georgia, United States

  • Facility name not stated

    Indianapolis, Indiana, United States

  • Facility name not stated

    Iowa City, Iowa, United States

  • Facility name not stated

    Lafayette, Louisiana, United States

  • Facility name not stated

    Lewiston, Maine, United States

  • Facility name not stated

    Takoma Park, Maryland, United States

  • Facility name not stated

    Kansas City, Missouri, United States

  • Facility name not stated

    Springfield, Missouri, United States

  • Facility name not stated

    Newark, New Jersey, United States

  • Facility name not stated

    New York, New York, United States

  • Facility name not stated

    New York, New York, United States

  • Facility name not stated

    Poughkeepsie, New York, United States

  • Facility name not stated

    Gastonia, North Carolina, United States

  • Facility name not stated

    High Point, North Carolina, United States

  • Facility name not stated

    Columbus, Ohio, United States

  • Facility name not stated

    Portland, Oregon, United States

  • Facility name not stated

    Anderson, South Carolina, United States

  • Facility name not stated

    Greenville, South Carolina, United States

  • Facility name not stated

    Amarillo, Texas, United States

  • Facility name not stated

    McKinney, Texas, United States

  • Facility name not stated

    Tyler, Texas, United States

  • Facility name not stated

    Mechanicsville, Virginia, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
30 Nov 2012
Primary completion
30 Sept 2015
Completion
30 Nov 2017
Last update posted
28 Sept 2018
Registered enrollment
329
Registry id
NCT01612767

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.